The muscle biopsy results from 14 children with macrocephaly and hypotonia/ weakness were correlated with clinical findings compatible with any of the autosomal dominant macrocephaly syndromes. Thirteen of the 14 
information consists predominantly of case reports or small series, except for a few older reports which generally contain little or no data applicable to resolving this issue. Macrocephaly with an autosomal dominant pattern of inheritance appears to be the most important unifying feature among the clinical findings reported for these disorders, but hamartomatous lesions are also quite common. Hypotonia associated with gross motor or global developmental delay appears to be prevalent and has in some cases of RMS been correlated with a characteristic myopathy.6 At present this lipid storage myopathy (LSM), described in several children and adults with the RMS phenotype, is probably the most specific marker for any of these conditions. Accordingly, a retrospective study was undertaken to assess the prevalence of LSM in children with macrocephaly and hypotonia/weakness in order to determine its prevalence in phenotypes other than RMS as a way of shedding additional light on the aetiology of these disorders. Evidence of LSM was found in all of the children with familial macrocephaly. In some cases the intracellular lipid was increased only in localised areas of the biopsy sections, but the neuropathologist noted this in reports written before discussion of the clinical information, making it unlikely that in these less well defined and perhaps somewhat subjective interpretations any bias based on clinical information was introduced. As an additional investigation of possible observer bias, all biopsy records of children with evidence of LSM were reviewed. Excluding the children known to have macrocephaly, in all but two other cases specific aetiologies for LSM, generally genetic or acquired metabolic disorders, had been identified. Further investigation of these two cases showed that both children had macrocephaly with a family pedigree containing a minimum of one affected parent. They have therefore been included in this analysis. Since a specific aetiology was identified in 100% of the children not in this study with biopsy evidence of LSM, our approach to identifying lipid storage myopathy would appear to be fairly objective. The biopsy results were consistent across all of the macrocephaly phenotypes observed. Biopsies from children with autosomal dominant macrocephaly alone were indistinguishable from those in which the clinical features were consistent with the BZ and RMS phenotypes, both with regard to the lipid distribution and the fibre size variation. Similarly, no obvious differences could be discerned between biopsies from boys or girls, although with only three girls included the numbers are too small to allow any great degree of confidence in this observation (table  2) . This high male/female ratio is puzzling for a condition with a well defined autosomal dominant mode of inheritance. Although it is probably remotely possible that boys are more likely to be referred for evaluation of hypotonia or weakness because of higher societal expectations for physically oriented behaviour, this seems unlikely as an explanation for the entire sex ratio anomaly. None of the affected parents had weakness or hypotonia at the time their children were evaluated. In virtually every case where a reliable developmental history was available for the parent, indications of delayed motor milestones were evident. A muscle biopsy was obtained from one parent during an elective procedure to remove a large lipoma. The histochemical appearance of this sample was indistinguishable from the biopsies in the children reported here and also in previously reported adults with the RMS phenotype. 6 The only child in this study without a macrocephalic parent had no abnormalities evident on his muscle biopsy despite the fact that he was profoundly hypotonic and had an abnormal EMG. Initially, with the exception of macrocephaly, he had an otherwise normal physical examination. As he grew older, however, he changed substantially and developed accelerated linear growth, particularly of the hands and feet. Ectopia lentis and echocardiographic features compatible with Marfan syndrome (MS) were subsequently detected. No evidence of homocystinuria was found after metabolic testing. Despite careful physical, ophthalmological, and echocardiographic examinations, neither parent had any evidence of MS. Neuromuscular problems do not seem to have been reported previously in infants with MS. Although in the absence of a family history the diagnosis of MS may not be absolutely certain, the physical, ophthalmological, and echocardiographic features in this child are highly suggestive of this disorder and fibrillin studies were also consistent.
The aetiology of the LSM in these children is unclear. Serum carnitine levels were normal in all four who were tested. One early report found normal muscle and serum carnitine levels in a single patient,6 but subsequent results suggest that the carnitine level may actually be low in skeletal muscle.11 This finding could certainly explain the LSM and weakness but must be confirmed. In spite of extensive metabolic evaluations of the children in the present report, no evidence of any inborn error of metabolism which might produce a secondary carnitine deficiency was identified. In particular, urinary organic acids and acyl carnitine fractionation by fast atom bombardment of urine samples obtained after carnitine loading were normal. Reduced skeletal muscle carnitine levels, if confirmed, in the setting of normal serum levels could perhaps result from a membrane transport defect in skeletal muscle. The normal metabolic studies and the autosomal dominant inheritance pattem make an enzymatic defect unlikely.
Based on an informal review of nearly 300 of the author's patients, whose evaluations included muscle biopsies, LSM associated with macrocephaly was the most frequent single diagnosis, exceeding the incidence of relatively common childhood neuromuscular disorders, such as Duchenne muscular dystrophy and spinal muscular atrophy, by a considerable amount. Since mildly affected children are probably not referred for evaluation if they do not fall too far behind in their gross motor development, the actual incidence of this condition may be even higher and it may easily be the most common myopathy of childhood. It must be remembered, however, that a biopsy from one of the previously reported patients was normal from one muscle group and markedly abnormal in another. This observation, coupled with the focal nature of the lipid anomaly in the biopsies in this report, makes it likely that not all children can be expected to have abnormal biopsy results and LSM should not be used as a necessary condition for the diagnosis of this condition.
Despite the fact that all of the children in this report were referred for evaluation of hypotonia or weakness rather than macrocephaly and hamartomata, this mode of ascertainment would not appear to introduce any systematic bias into the study which would alter the conclusions. Although skeletal muscle biopsies have not been obtained from children with familial macrocephaly and normal muscle strength and tone, previously published biopsy results in adults with the RMS phenotype but no evidence of weakness have also shown LSM,6 making it unlikely that children would be unaffected.
The presence of an unusual histochemical marker, LSM, in all evaluated children with the BZ, RMS, and BFM phenotypes would appear to be strong evidence in favour of unifying these previously separate disorders into a single autosomal dominant syndrome with macrocephaly, hamartomata, and LSM as the cardinal manifestations. Although many other associated abnormalities have been observed, none appears to be as characteristic as these three. Unfortunately, no children with the RS phenotype were identified in this study. One child with familial macrocephaly, haemangiomata, profound hypotonia, and normal social and cognitive development was evaluated, but the family declined a muscle biopsy. The findings on the neuromuscular examination were comparable to the children who did have biopsies, however, suggesting that similar histochemical results may also have been found. Histochemical examination of skeletal muscle biopsies for the discrete marker, LSM, appears to be useful for resolving clinical ambiguities related to the autosomal dominant macrocephaly syndromes and should help to further analysis and understanding of this disorder, particularly as molecular approaches are applied in the future. This paper was presented in part at the American Pediatric Society/Society for Paediatric Research meeting, New Orleans, Louisiana, 29 April to 2 May 1991. The author wishes to acknowledge the assistance of the late Dr David Hollister whose laboratory performed the fibrillin studies on thle patient with Marfan syndrome.
